Bisphosphonate-induced atypical femoral fracture in tandem: long-term follow-up is warranted
Although bisphosphonates (BPs) are mainly used for the treatment of osteoporosis and are generally safe, long-term use and more dosage as utilised in malignant conditions may be associated with the rare adverse event of an atypical femoral fracture (AFF). Occasionally, the risk of developing an AFF...
Main Authors: | Mohammed Anwar Hussain, Aneez Joseph, Vinoo Mathew Cherian, Alok Srivastava, Kripa Elizabeth Cherian, Nitin Kapoor, Thomas Vizhalil Paul |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2022-08-01
|
Series: | Endocrinology, Diabetes & Metabolism Case Reports |
Online Access: | https://edm.bioscientifica.com/view/journals/edm/2022/1/EDM22-0249.xml |
Similar Items
-
Utility of FRAX (fracture risk assessment tool) in primary care and family practice setting in India
by: Kripa Elizabeth Cherian, et al.
Published: (2019-01-01) -
Excess dietary salt is associated with an altered bone strain index, degraded bone microarchitecture, vertebral fractures, and increased prevalence of osteoporosis in postmenopausal women—A study from a teaching hospital in southern India
by: Rebecca John, et al.
Published: (2024-10-01) -
Glucocorticoid-induced osteoporosis
by: Kripa Elizabeth Cherian, et al.
Published: (2017-01-01) -
GGPS1 mutation and atypical femoral fractures with bisphosphonates.
by: Roca-Ayats, N, et al.
Published: (2017) -
Bilateral atypical femoral fracture related to bisphosphonate therapy
by: Savić Aleksandra, et al.
Published: (2022-01-01)